MiR-214 can further enhance ferroptosis inducer erastin-induced reduction of GSH and accumulation of ROS and MDA in HCC cells by downregulating the expression of ferroptosis negative regulator ATF4, thus enhancing ferroptosis in HCC cells (105). This evidence concerns the gene ATF4 and hepatocellular carcinoma.